• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受左旋多巴-卡比多巴肠凝胶输注的患者的中枢传导异常。

Central conduction abnormalities in patients receiving levodopa-carbidopa intestinal gel infusion.

机构信息

Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli, Institute of Neurology, Largo A. Gemelli, 8, 00168, Rome, Italy.

Fondazione Don Carlo Gnocchi, Milan, Italy.

出版信息

Neurol Sci. 2017 Oct;38(10):1869-1872. doi: 10.1007/s10072-017-3029-z. Epub 2017 Jun 22.

DOI:10.1007/s10072-017-3029-z
PMID:28642996
Abstract

In recent years, several studies have reported a relatively high frequency of polyneuropathy in patients with Parkinson's disease (PD), in particular, in patients receiving levodopa-carbidopa intestinal gel (LCIG) infusion. In spite of the several patients investigated with nerve conduction studies, no study has prospectively explored a possible central nervous system involvement of patients receiving LCIG infusion. We prospectively evaluated eight PD patients receiving LCIG infusion, who underwent neurophysiological evaluations with nerve conduction studies, visual, somatosensory and motor evoked potentials before LCIG infusion, and 1 and 6 months after. At 6 months follow-up, we found significant reduction in sural nerve SNAP amplitude, increase of central sensory conduction time N22-P40, and increases of central motor conduction time recorded from I dorsal interosseous and tibialis anterior. In PD patients with LCIG infusion, we found a subclinical neurophysiological impairment of both peripheral and central nervous system.

摘要

近年来,多项研究报告了帕金森病(PD)患者多发性神经病的相对高发率,特别是接受左旋多巴-卡比多巴肠凝胶(LCIG)输注的患者。尽管有几项研究对神经传导研究进行了调查,但没有研究前瞻性地探讨接受 LCIG 输注的患者可能存在中枢神经系统受累。我们前瞻性地评估了 8 例接受 LCIG 输注的 PD 患者,他们在接受 LCIG 输注前、输注后 1 个月和 6 个月进行了神经生理学评估,包括神经传导研究、视觉、体感和运动诱发电位。在 6 个月的随访中,我们发现腓肠神经 SNAP 振幅显著降低,N22-P40 感觉中枢传导时间延长,I 骨间背侧和胫骨前肌记录的中枢运动传导时间延长。在接受 LCIG 输注的 PD 患者中,我们发现了外周和中枢神经系统的亚临床神经生理学损伤。

相似文献

1
Central conduction abnormalities in patients receiving levodopa-carbidopa intestinal gel infusion.接受左旋多巴-卡比多巴肠凝胶输注的患者的中枢传导异常。
Neurol Sci. 2017 Oct;38(10):1869-1872. doi: 10.1007/s10072-017-3029-z. Epub 2017 Jun 22.
2
Peripheral neuropathy associated with levodopa-carbidopa intestinal infusion: a long-term prospective assessment.左旋多巴-卡比多巴肠道灌注相关的周围神经病变:一项长期前瞻性评估
Eur J Neurol. 2016 Mar;23(3):501-9. doi: 10.1111/ene.12846. Epub 2015 Oct 25.
3
Peripheral neuropathy in 30 duodopa patients with vitamins B supplementation.30 例接受维生素 B 补充的多巴丝肼患者的周围神经病。
Acta Neurol Scand. 2017 Dec;136(6):660-667. doi: 10.1111/ane.12783. Epub 2017 Jun 12.
4
Jejunal Infusion of levodopa-carbidopa intestinal gel versus oral administration of levodopa-carbidopa tablets in japanese subjects with advanced Parkinson's disease: pharmacokinetics and pilot efficacy and safety.左旋多巴-卡比多巴肠凝胶空肠输注与左旋多巴-卡比多巴片口服给药治疗日本晚期帕金森病患者的药代动力学、初步疗效及安全性比较
Clin Pharmacokinet. 2015 Sep;54(9):975-84. doi: 10.1007/s40262-015-0265-3.
5
Levodopa-Carbidopa Intestinal Gel Infusion Therapy in Advanced Parkinson's Disease: Single Middle Eastern Center Experience.左旋多巴-卡比多巴肠凝胶输注疗法治疗晚期帕金森病:中东单一中心经验
Eur Neurol. 2015;74(5-6):227-36. doi: 10.1159/000442151. Epub 2015 Dec 1.
6
Levodopa/carbidopa intestinal gel infusion and weight loss in Parkinson's disease.左旋多巴/卡比多巴肠凝胶输注与帕金森病的体重减轻。
Eur J Neurol. 2019 Mar;26(3):490-496. doi: 10.1111/ene.13844. Epub 2018 Nov 18.
7
Levodopa-Carbidopa Intestinal Gel Monotherapy: GLORIA Registry Demographics, Efficacy, and Safety.左旋多巴-卡比多巴肠凝胶单药治疗:GLORIA 注册研究的人口统计学、疗效和安全性。
J Parkinsons Dis. 2019;9(3):531-541. doi: 10.3233/JPD-191605.
8
Intraduodenal levodopa-carbidopa intestinal gel infusion improves both motor performance and quality of life in advanced Parkinson's disease.十二指肠内左旋多巴-卡比多巴肠凝胶输注可改善晚期帕金森病的运动功能和生活质量。
J Clin Neurosci. 2016 Mar;25:41-5. doi: 10.1016/j.jocn.2015.05.059. Epub 2016 Jan 14.
9
Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry.左旋多巴-卡比多巴肠凝胶治疗晚期帕金森病:GLORIA 登记研究的最终结果。
Parkinsonism Relat Disord. 2017 Dec;45:13-20. doi: 10.1016/j.parkreldis.2017.09.018. Epub 2017 Sep 22.
10
Long-term response to continuous duodenal infusion of levodopa/carbidopa gel in patients with advanced Parkinson disease: The Barcelona registry.晚期帕金森病患者对左旋多巴/卡比多巴凝胶持续十二指肠输注的长期反应:巴塞罗那登记研究
Parkinsonism Relat Disord. 2015 Aug;21(8):871-6. doi: 10.1016/j.parkreldis.2015.05.014. Epub 2015 May 19.

本文引用的文献

1
Polyneuropathy associated with duodenal infusion of levodopa in Parkinson's disease: features, pathogenesis and management.与帕金森病中十二指肠输注左旋多巴相关的多发性神经病:特征、发病机制与管理。
J Neurol Neurosurg Psychiatry. 2015 May;86(5):490-5. doi: 10.1136/jnnp-2014-308586. Epub 2014 Aug 28.
2
Prevalence and features of peripheral neuropathy in Parkinson's disease patients under different therapeutic regimens.不同治疗方案下帕金森病患者周围神经病变的患病率及特征。
Parkinsonism Relat Disord. 2014 Jan;20(1):27-31. doi: 10.1016/j.parkreldis.2013.09.007. Epub 2013 Sep 25.
3
Subacute axonal neuropathy in Parkinson's disease with cobalamin and vitamin B6 deficiency under duodopa therapy.
多潘立酮治疗下的帕金森病伴钴胺素和维生素 B6 缺乏的亚急性轴索性神经病。
Mov Disord. 2010 Aug 15;25(11):1748-52. doi: 10.1002/mds.23342.
4
Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy.帕金森病患者在使用多聚左旋多巴治疗期间出现的可逆性脑病和轴索性神经病。
Mov Disord. 2009 Nov 15;24(15):2293-4. doi: 10.1002/mds.22807.
5
Current concepts in the diagnosis of cobalamin deficiency.钴胺素缺乏症诊断的当前概念
Neurology. 1995 Aug;45(8):1435-40. doi: 10.1212/wnl.45.8.1435.